Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
Argus Health
Healthtrust
Julphar
Farmers Insurance
Johnson and Johnson
Merck
Medtronic

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BEPOTASTINE BESILATE

« Back to Dashboard

Clinical Trials for Bepotastine Besilate

Trial ID Title Status Sponsor Phase Summary
NCT00424398 Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis Completed Bausch & Lomb Incorporated Phase 2/Phase 3 The purpose of this study is to evaluate whether bepotastine besilate ophthalmic solution is effective in the treatment of acute allergic conjunctivitis
NCT00586625 Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers Completed Bausch & Lomb Incorporated Phase 3 Safety study for bepotastine besilate ophthalmic solution in normal volunteers
NCT00586664 Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Completed Bausch & Lomb Incorporated Phase 3 Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis
NCT01174823 Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis Patients Completed Bausch & Lomb Incorporated Phase 2 The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.
NCT01222299 Safety and Efficacy of Bepotastine Besilate Nasal Product in Seasonal Allergic Rhinitis Patients Completed Bausch & Lomb Incorporated Phase 1/Phase 2 The purpose of this study is to examine the safety and efficacy of bepotastine besilate nasal product in seasonal allergic rhinitis patients.
NCT01277341 Safety and Efficacy of Bepotastine in the Treatment of Seasonal Allergic Rhinitis Completed Bausch & Lomb Incorporated Phase 2 This is an efficacy study of bepotastine besilate nasal spray in seasonal allergic rhinitis.
NCT01337557 Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses Enrolling by invitation Bausch & Lomb Incorporated Phase 4 The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Bepotastine Besilate

Condition Name

Condition Name for Bepotastine Besilate
Intervention Trials
Allergic Conjunctivitis 6
Seasonal Allergic Rhinitis 3
Healthy 3
Allergic Rhinitis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Bepotastine Besilate
Intervention Trials
Conjunctivitis, Allergic 7
Conjunctivitis 7
Rhinitis, Allergic 7
Rhinitis 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Bepotastine Besilate

Trials by Country

Trials by Country for Bepotastine Besilate
Location Trials
United States 10
Korea, Republic of 3
Japan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Bepotastine Besilate
Location Trials
California 8
Tennessee 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Bepotastine Besilate

Clinical Trial Phase

Clinical Trial Phase for Bepotastine Besilate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 5
Phase 2/Phase 3 1
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Bepotastine Besilate
Clinical Trial Phase Trials
Completed 16
Recruiting 1
Unknown status 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Bepotastine Besilate

Sponsor Name

Sponsor Name for Bepotastine Besilate
Sponsor Trials
Bausch & Lomb Incorporated 10
Mitsubishi Tanabe Pharma Corporation 3
Hom, Milton M., OD, FAAO 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Bepotastine Besilate
Sponsor Trials
Industry 18
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
AstraZeneca
Fuji
Mallinckrodt
Covington
Cerilliant
Healthtrust
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.